Results 171 to 180 of about 4,346,534 (345)

HBV-DNA and Primary Immune Complex Glomerulonephritis [PDF]

open access: yesNephron, 2008
G, Rostoker   +7 more
openaire   +2 more sources

Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps

open access: yesTransplant Infectious Disease, EarlyView.
ABSTRACT Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people.
Oscar A. Fernandez‐Garcia   +3 more
wiley   +1 more source

HTLV screening and confirmatory testing among blood donors in São Paulo: A cross‐sectional study

open access: yesTransfusion Medicine, EarlyView.
Abstract Introduction Human T‐cell lymphotropic virus types 1 and 2 (HTLV‐1/2) are transfusion‐transmissible retroviruses associated with severe diseases, and blood donor screening is mandatory in Brazil. Increasing HTLV‐related discard rates at our institution prompted this study to determine the prevalence and incidence of HTLV‐1/2 and to investigate
Suzete C. Ferreira   +11 more
wiley   +1 more source

Identifying blood deserts in Liberia: A geospatial analysis

open access: yesTransfusion, EarlyView.
Abstract Background Understanding patterns in blood availability is key to identifying appropriate interventions to increase blood access, particularly interventions intended for use in blood deserts, defined as areas in which >75% of blood needs are unmet.
Laura Jean Ridge   +4 more
wiley   +1 more source

Budget impact of implementing universal Plasmodium NAT screening in the blood transfusion system in the US

open access: yesTransfusion, EarlyView.
Abstract Background Blood donor deferral for malaria risk relies exclusively on responses to self‐reported questionnaires. This study evaluated the economic impact of introducing Plasmodium nucleic acid testing (NAT) as a universal screening strategy in the United States.
Cristina Coll‐Ortega   +3 more
wiley   +1 more source

HBV-DNA levels predict overall mortality in HIV/HBV coinfected individuals

open access: yes, 2016
The coinfection of Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) has been associated with increased death rates. However, the relevant research has mostly relied on serologic HBV testing [HBV surface antigen (HBsAg)].
Psichogiou, M.   +3 more
core   +1 more source

Passive acquisition of hepatitis B virus antibodies after allogeneic hematopoietic cell transplantation

open access: yesTransfusion, EarlyView.
Abstract Background Newly positive hepatitis B virus (HBV) serologic results after allogeneic hematopoietic cell transplantation (HCT) may reflect passive antibody transfer from blood‐derived products rather than HBV infection. We investigated the incidence and temporal patterns of hepatitis B surface antibody (anti‐HBs) and antibody to hepatitis B ...
Takaaki Konuma   +7 more
wiley   +1 more source

A comparative viral load evaluation for human immunodeficiency virus, hepatitis B virus and hepatitis C virus of the Roche cobas 5800, Abbott Alinity m and Hologic Panther

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Viral load (VL) quantification for human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) is essential for clinical monitoring, treatment response assessment and post‐donation interpretation.
Adriaan Meyer, Suné Saayman
wiley   +1 more source

HIV Testing and Care Among Publicly Insured Enrollees With Schizophrenia: Is There a Benefit to Dual Eligibility?

open access: yesPsychiatric Research and Clinical Practice, EarlyView.
Background Patients with schizophrenia experience gaps in the human immunodeficiency virus (HIV) care continuum. We examined the impact of dual enrollment in Medicare upon HIV testing and retention among Medicaid‐enrolled patients with schizophrenia.
Karly Murphy   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy